Kang‐Yung Peng

1.6k citations

60 papers · 1.3k indexed · h-index 23

Polymers and Plastics top 5%
- Conducting polymers and applications 15
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension 29
- Adrenal Hormones and Disorders 15
Electrical and Electronic Engineering top 5%
- Organic Electronics and Photovoltaics 22
- Organic Light-Emitting Diodes Research 17
Materials Chemistry
- Luminescence and Fluorescent Materials 5
Surgery top 10%
- Adrenal and Paraganglionic Tumors 24
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4

Co-authors: Show‐An Chen Wunshain Fann S. A. Chen Vin‐Cent Wu A. C. Su Anto R. Inigo Yen‐Hung Lin J. D. White
Cited by: Polymers and Plastics Endocrinology, Diabetes and Metabolism Electrical and Electronic Engineering
Journals: Journal of the American Chemical Society (1 paper)Physical Review Letters (2 papers)Advanced Materials (3 papers)
Partner nations: Taiwan United States China

In The Last Decade

Kang‐Yung Peng

58 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kang‐Yung Peng

Since Specialization

Citations

This map shows the geographic impact of Kang‐Yung Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang‐Yung Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang‐Yung Peng more than expected).

Fields of papers citing papers by Kang‐Yung Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang‐Yung Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang‐Yung Peng. The network helps show where Kang‐Yung Peng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kang‐Yung Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kang‐Yung Peng Line = papers co-authored together Kang‐Yung Peng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	C-terminal FGF-23 production coupling with aldosterone via FAM20C and predicting cardiovascular events in primary aldosteronism JCI Insight ·Vin‐Cent Wu,Kang‐Yung Peng,T S Chen,Chiao-Yin Sun,Hung‐Wei Liao,Chieh‐Kai Chan,Yen‐Hung Lin,Hung-Hsiang Liou,Shih‐Chieh Chueh	2025	1
2	The predictors of long-term outcomes after targeted therapy for primary Aldosteronism Journal of the Formosan Medical Association ·Ying-Ying Chen,Shun‐Chen Huang,Chien‐Ting Pan,Kang‐Yung Peng,Liang‐Yu Lin,Chieh‐Kai Chan,Chia‐Tung Shun	2023	1
3	Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism Journal of the Formosan Medical Association ·Chi‐Shin Tseng,Chieh‐Kai Chan,Hsiang‐Ying Lee,Chien‐Ting Pan,Kang‐Yung Peng,Shuo‐Meng Wang,Kuo‐How Huang,Yao‐Chou Tsai,Vin‐Cent Wu,Shih‐Chieh Chueh	2023	8
4	Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes The Journal of Clinical Endocrinology & Metabolism ·Vin‐Cent Wu,Kang‐Yung Peng,Ya-Hui Hu,Chin‐Chen Chang,Chieh‐Kai Chan,Tai‐Shuan Lai,Yen‐Hung Lin,Shuo‐Meng Wang,Ching‐Chu Lu,Yu-Chun Liu,Yao‐Chou Tsai,Shih‐Chieh Chueh	2022	1
5	A Novel Somatic Mutation of CACNA1H p.V1937M in Unilateral Primary Hyperaldosteronism Frontiers in Endocrinology ·Chi‐Shin Tseng,Kang‐Yung Peng,Shuo‐Meng Wang,Yao‐Chou Tsai,Kuo‐How Huang,Wei‐Chou Lin,Ya‐Hui Hu,Vin‐Cent Wu,Shih‐Chieh Chueh	2022	3
6	Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology Frontiers in Endocrinology ·Yi–Ju Chen,Kang‐Yung Peng,Shih‐Chieh Chueh,Hung‐Wei Liao,Tsung-Yi Hsieh,Vin‐Cent Wu,Shuo‐Meng Wang	2022	5
7	Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism Biomedicines ·Chung‐Yi Cheng,Hung‐Wei Liao,Kang‐Yung Peng,Tso-Hsiao Chen,Yen‐Hung Lin,Shih‐Chieh Chueh,Vin‐Cent Wu,(unknown)	2021	4
8	KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness Cancers ·Yi‐Yao Chang,Chien‐Ting Pan,Zheng‐Wei Chen,Cheng‐Hsuan Tsai,Shih‐Yuan Peng,Chin‐Chen Chang,Bo‐Ching Lee,Che‐Wei Liao,Kang‐Yung Peng,Yu‐Wei Chiu,Chia‐Hung Chou,Vin‐Cent Wu,Liyu Liu,Chi‐Sheng Hung,Yen‐Hung Lin	2021	6
9	Pathophysiological and Pharmacological Characteristics of KCNJ5 157-159delITE Somatic Mutation in Aldosterone-Producing Adenomas Biomedicines ·Kang‐Yung Peng,Hung‐Wei Liao,Shih‐Chieh Chueh,Chien‐Yuan Pan,Yen‐Hung Lin,Yung‐Ming Chen,Peng-Ying Chen,Chun‐Lin Huang,Vin‐Cent Wu	2021	4
10	Novel Mutations Detection with Next-Generation Sequencing and Its Association with Clinical Outcome in Unilateral Primary Aldosteronism Biomedicines ·Che‐Hsiung Wu,Kang‐Yung Peng,Daw‐Yang Hwang,Yen‐Hung Lin,Vin‐Cent Wu,Shih‐Chieh Chueh	2021	7
11	GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism BMC Bioinformatics ·Yu‐Ching Wu,Chia-I Chen,Peng-Ying Chen,Chun-Hung Kuo,Yi-Hsuan Hung,Kang‐Yung Peng,Vin‐Cent Wu,Jyy-Jih Tsai-Wu,Chia‐Lang Hsu,(unknown)	2021	2
12	NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients Frontiers in Endocrinology ·Ching‐Chu Lu,Ruoh‐Fang Yen,Kang‐Yung Peng,Jei‐Yie Huang,Kwan‐Dun Wu,Shih‐Chieh Chueh,Wan‐Yu Lin	2021	4
13	KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function Hypertension ·Yi‐Yao Chang,Cheng‐Hsuan Tsai,Shih‐Yuan Peng,Zheng‐Wei Chen,Chin‐Chen Chang,Bo‐Ching Lee,Che‐Wei Liao,Chien‐Ting Pan,Yali Chen,Lung‐Chun Lin,Yi‐Ru Chang,Kang‐Yung Peng,Chia‐Hung Chou,Vin‐Cent Wu,Chi‐Sheng Hung,Yen‐Hung Lin,(unknown)	2020	20
14	Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism Endocrinology and Metabolism ·Yu-Fang Lin,Kang‐Yung Peng,Chia‐Hui Chang,Ya‐Hui Hu,Vin‐Cent Wu,Shiu‐Dong Chung,(unknown)	2020	10
15	Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population Scientific Reports ·Vin‐Cent Wu,Kuo‐How Huang,Kang‐Yung Peng,Yao‐Chou Tsai,Che‐Hsiung Wu,Shuo‐Meng Wang,Shao‐Yu Yang,Lian‐Yu Lin,Chin‐Chen Chang,Yen‐Hung Lin,Shuei‐Liong Lin,Tzong‐Shinn Chu,Kwan‐Dun Wu	2015	77
16	Hemojuvelin Modulates Iron Stress During Acute Kidney Injury: Improved by Furin Inhibitor Antioxidants and Redox Signaling ·Guang‐Huar Young,Tao‐Min Huang,Che‐Hsiung Wu,Chun‐Fu Lai,Chun‐Cheng Hou,Kang‐Yung Peng,Chan‐Jung Liang,Shuei‐Liong Lin,Shih‐Chung Chang,Hung‐Bin Tsai,Kwan‐Dun Wu,Vin‐Cent Wu,Wen‐Je Ko,(unknown)	2013	22
17	Antiosteoporotic Activity of Dioscorea alata L. cv. Phyto through Driving Mesenchymal Stem Cells Differentiation for Bone Formation Evidence-based Complementary and Alternative Medicine ·Kang‐Yung Peng,Lin‐Yea Horng,Hui‐Ching Sung,Hui‐Chuan Huang,Rong-Tsun Wu	2011	19
18	Hepatocyte growth factor has a role in the amelioration of diabetic vascular complications via autophagic clearance of advanced glycation end products: Dispo85E, an HGF inducer, as a potential botanical drug Metabolism ·Kang‐Yung Peng,Lin‐Yea Horng,Hui‐Ching Sung,Hui‐Chuan Huang,Rong-Tsun Wu	2010	19
19	Aggregate versus Excimer Emissions from Poly(2,5-di-n-octyloxy-1,4-phenylenevinylene) The Journal of Physical Chemistry C ·Yan‐Qin Huang,Y. J. Shiu,Jui Hsu,S. H. Lin,A. C. Su,Kang‐Yung Peng,S. A. Chen,Wunshain Fann	2007	36
20	Well-Packed Chains and Aggregates in the Emission Mechanism of Conjugated Polymers The Journal of Physical Chemistry B ·Kang‐Yung Peng,Show‐An Chen,Wunshain Fann,Suhua Chen,An‐Chung Su	2005	53

About Kang‐Yung Peng

Kang‐Yung Peng is a scholar working on Endocrinology, Diabetes and Metabolism, Polymers and Plastics and Surgery, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (29 papers), Adrenal and Paraganglionic Tumors (24 papers), Organic Electronics and Photovoltaics (22 papers), Organic Light-Emitting Diodes Research (17 papers), Conducting polymers and applications (15 papers), Adrenal Hormones and Disorders (15 papers), Luminescence and Fluorescent Materials (5 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). The work is most often cited by research in Polymers and Plastics (519 citations), Endocrinology, Diabetes and Metabolism (321 citations) and Electrical and Electronic Engineering (710 citations). Kang‐Yung Peng has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Show‐An Chen, Wunshain Fann, S. A. Chen, Vin‐Cent Wu, A. C. Su, Anto R. Inigo, Yen‐Hung Lin, J. D. White, Shih‐Chieh Chueh and Kuo‐How Huang. Their work appears in journals such as Journal of the American Chemical Society, Physical Review Letters and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact